Table of Contents
Journal of Viruses
Volume 2014 (2014), Article ID 691953, 5 pages
http://dx.doi.org/10.1155/2014/691953
Research Article

Hepatitis B Virus Seroprevalence and Serology Patterns in a Cohort of HIV Positive Individuals from Harare, Zimbabwe

1Division of Basic Medical Sciences, National University of Science and Technology, P.O. Box AC939, Ascot, Bulawayo, Zimbabwe
2Department of Medical Microbiology, University of Zimbabwe College of Health Sciences, Mazowe Street, P.O. Box A178, Avondale, Harare, Zimbabwe

Received 19 September 2014; Accepted 4 November 2014; Published 27 November 2014

Academic Editor: Massimo Ciccozzi

Copyright © 2014 Mayibongwe Louis Mzingwane and Tafadzwa Mamvura. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. Hoffmann and C. L. Thio, “Clinical implications of HIV and hepatitis B co-infection in Asia and Africa,” The Lancet Infectious Diseases, vol. 7, no. 6, pp. 402–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organisation Fact sheet no. 204, July 2012, http://www.who.int/mediacentre/factsheets/fs204/en/index.html.
  3. S. Tswana, C. Chetsanga, L. Nyström, S. Moyo, M. Nzara, and L. Chieza, “A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe,” South African Medical Journal, vol. 86, no. 1, pp. 72–75, 1996. View at Google Scholar · View at Scopus
  4. UNAIDS Global AIDS response progress report 2012, http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_ZW_Narrative_Report.pdf.
  5. R. J. Burnett, G. Francois, M. C. Kew et al., “Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation,” Liver International, vol. 25, no. 2, pp. 201–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. H. Mayaphi, T. M. Rossouw, D. P. Masemola, S. A. Olorunju, M. Jeffrey Mphahlele, and D. J. Martin, “HBV/HIV co-infection: the dynamics of HBV in South African patients with AIDS,” South African Medical Journal, vol. 102, no. 3, pp. 157–162, 2012. View at Google Scholar · View at Scopus
  7. A. Lukhwareni, R. J. Burnett, S. G. Selabe, M. O. Mzileni, and M. J. Mphahlele, “Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a tertiary hospital,” Journal of Medical Virology, vol. 81, no. 3, pp. 406–412, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. P. Desmond, S. Gaudieri, I. R. James et al., “Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e Antigen-Negative Disease,” Journal of Virology, vol. 86, no. 2, pp. 1181–1192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. K. Sterling, “Hepatitis B Virus in the Setting of HIV Infection: A Clinical Challenge,” Medical writers circle, 2003, http://www.hcvadvocate.org/hcsp/articles/Sterling-1.html.
  10. N. J. Bodsworth, D. A. Cooper, and B. Donovan, “The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state,” The Journal of Infectious Diseases, vol. 163, no. 5, pp. 1138–1140, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. C. L. Thio, E. C. Seaberg, R. Skolasky Jr. et al., “HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS),” The Lancet, vol. 360, no. 9349, pp. 1921–1926, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. T. E. M. S. De Vriessluijs, J. G. P. Reijnders, B. E. Hansen et al., “Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis b virus,” Gastroenterology, vol. 139, no. 6, pp. 1934–1941, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Stephan, A. Berger, A. Carlebach et al., “Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus,” Journal of Antimicrobial Chemotherapy, vol. 56, no. 6, pp. 1087–1093, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. B. Ristig, J. Crippin, J. A. Aberg et al., “Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-α and lamivudine therapy have failed,” Journal of Infectious Diseases, vol. 186, no. 12, pp. 1844–1847, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. C. L. Thio, “Hepatitis B and human immunodeficiency virus coinfection,” Hepatology, vol. 49, no. 5, pp. S138–S145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Ramezani, M. Banifazl, M. Mohraz, M. Rasoolinejad, and A. Aghakhani, “Occult hepatitis B virus infection: a major concern in HIV-infected patients,” Hepatitis Monthly, vol. 11, no. 1, pp. 7–10, 2011. View at Google Scholar · View at Scopus
  17. V. C. Kantelhardt, A. Schwarz, U. Wend et al., “Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen,” Journal of Clinical Virology, vol. 46, no. 2, pp. 124–128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. K. C. Kapembwa, J. D. Goldman, and S. Lakhi, “HIV, Hepatitis B, and Hepatitis C in Zambia,” Journal of Global Infectious Diseases, vol. 3, no. 3, pp. 269–274, 2011. View at Publisher · View at Google Scholar
  19. O. A. Ejele, C. A. Nwauche, and O. Erhabor, “The prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta Nigeria,” Nigerian Journal of Medicine, vol. 13, no. 2, pp. 175–179, 2004. View at Google Scholar · View at Scopus
  20. M. N. Mulders, V. Venard, M. Njayou et al., “Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa,” The Journal of Infectious Diseases, vol. 190, no. 2, pp. 400–408, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Rouet, M. L. Chaix, A. Inwoley et al., “HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: The ANRS 1236 study,” Journal of Medical Virology, vol. 74, no. 1, pp. 34–40, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. J. J. Ott, G. A. Stevens, J. Groeger, and S. T. Wiersma, “Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity,” Vaccine, vol. 30, no. 12, pp. 2212–2219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. GAVI ALLIANCE, “Investing in immunisation through the GAVI Alliance. The evidence base,” http://www.gavi.org/library/publications/the-evidence-base/investing-in-immunisation-through-the-gavi-alliance––the-evidence-base/.
  24. E. A. Santos, M. V. Sucupira, J. Arabe, and S. A. Gomes, “Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine,” BMC Infectious Diseases, vol. 4, article 29, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. N. J. Shire, S. D. Rouster, N. Rajicic, and K. E. Sherman, “Occult hepatitis B in HIV-infected patients,” Journal of Acquired Immune Deficiency Syndromes, vol. 36, no. 3, pp. 869–875, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Neau, M. Winnock, T. Galperine et al., “Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients,” HIV Medicine, vol. 5, no. 3, pp. 171–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. M. K. Osborn, J. L. Guest, and D. Rimland, “Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease,” HIV Medicine, vol. 8, no. 5, pp. 271–279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Kallestrup, R. Zinyama, E. Gomo et al., “Low prevalence of hepatitis C virus antibodies in HIV-endemic area of Zimbabwe support sexual transmission as the major route of HIV transmission in Africa,” AIDS, vol. 17, no. 9, pp. 1400–1402, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. B. C. Gärtner, W. Jung, C. Welsch et al., “Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantation,” Journal of Clinical Virology, vol. 38, no. 2, pp. 146–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Awerkiew, M. Däumer, M. Reiser et al., “Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient,” Journal of Clinical Virology, vol. 38, no. 1, pp. 83–86, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Avettand-Fenoel, D. Thabut, C. Katlama, T. Poynard, and V. Thibault, “Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection,” Journal of Clinical Microbiology, vol. 44, no. 6, pp. 2250–2253, 2006. View at Publisher · View at Google Scholar · View at Scopus